Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Apr. 19];2:S79. Available from: https://skin.dermsquared.com/skin/article/view/475